Stock Analysis on Net
Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

Paying users zone. Data is hidden behind: .

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Pfizer Inc. pages available today for free:

Common-Size Income Statement
Quarterly Data

Pfizer Inc., common-size consolidated income statement (quarterly data)

Microsoft Excel LibreOffice Calc
3 months ended: Jul 4, 2021 Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 31, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Oct 2, 2016 Jul 3, 2016 Apr 3, 2016
Revenues
Cost of sales
Gross profit
Selling, informational and administrative expenses
Research and development expenses
Amortization of intangible assets
Restructuring charges and certain acquisition-related costs
Operating income
Gain on completion of Consumer Healthcare JV transaction
Other income (deductions), net
Income from continuing operations before (provision) benefit for taxes on income
(Provision) benefit for taxes on income
Income from continuing operations
Income from discontinued operations, net of tax
Net income before allocation to noncontrolling interests
Net income attributable to noncontrolling interests
Net income attributable to Pfizer Inc.
Preferred stock dividends, net of tax
Net income attributable to Pfizer Inc. common shareholders

Based on: 10-Q (filing date: 2021-08-12), 10-Q (filing date: 2021-05-13), 10-K (filing date: 2021-02-25), 10-Q (filing date: 2020-11-05), 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-K (filing date: 2020-02-27), 10-Q (filing date: 2019-11-07), 10-Q (filing date: 2019-08-08), 10-Q (filing date: 2019-05-09), 10-K (filing date: 2019-02-28), 10-Q (filing date: 2018-11-08), 10-Q (filing date: 2018-08-09), 10-Q (filing date: 2018-05-10), 10-K (filing date: 2018-02-22), 10-Q (filing date: 2017-11-09), 10-Q (filing date: 2017-08-10), 10-Q (filing date: 2017-05-11), 10-K (filing date: 2017-02-23), 10-Q (filing date: 2016-11-10), 10-Q (filing date: 2016-08-11), 10-Q (filing date: 2016-05-12).

Income statement item Description The company
Operating income The net result for the period of deducting operating expenses from operating revenues. Pfizer Inc.’s operating income as a percentage of revenues increased from Q4 2020 to Q1 2021 but then slightly decreased from Q1 2021 to Q2 2021.
Income from continuing operations before (provision) benefit for taxes on income Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Pfizer Inc.’s income from continuing operations before (provision) benefit for taxes on income as a percentage of revenues increased from Q4 2020 to Q1 2021 but then slightly decreased from Q1 2021 to Q2 2021.
Net income attributable to Pfizer Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Pfizer Inc.’s net income attributable to Pfizer Inc. as a percentage of revenues increased from Q4 2020 to Q1 2021 but then slightly decreased from Q1 2021 to Q2 2021.